Valion Bio(VBIO)
$0.50-0.03 (-4.92%)
VBIO
Valion Bio financials statements
$0.50
At close:-0.03 (-4.92%)
Want to see VBIO full AI Analyst Report?
Valion Bio (VBIO) Ratios
175 Followers
Valion Bio Ratios
VBIO's free cash flow for Q2 2026 was $-2.01M. For the 2026 fiscal year, VBIO's free cash flow was decreased by $-10.00K and operating cash flow was $-2.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 24 | Dec 23 | Mar 23 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 20.13 | 9.70 | 20.13 | 3.32 | 2.51 |
| Quick Ratio | 20.13 | 8.53 | 20.13 | 2.78 | 2.05 |
| Cash Ratio | 19.57 | 7.36 | 19.57 | 2.42 | 1.87 |
| Solvency Ratio | -0.60 | -19.50 | -0.60 | -5.11 | -4.15 |
| Operating Cash Flow Ratio | -10.83 | -21.05 | -10.83 | -6.07 | -4.75 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | -54.72 |
| Net Current Asset Value | $ -1.80M | $ 2.37M | $ -1.80M | $ 3.08M | $ 2.33M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.20 | 0.00 | 0.20 | 0.07 | 0.09 |
| Debt-to-Equity Ratio | 0.38 | 0.00 | 0.38 | 0.10 | 0.15 |
| Debt-to-Capital Ratio | 0.28 | 0.00 | 0.28 | 0.09 | 0.13 |
| Long-Term Debt-to-Capital Ratio | 0.28 | 0.00 | 0.28 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.88 | 1.11 | 1.88 | 1.44 | 1.66 |
| Debt Service Coverage Ratio | -53.71 | 0.00 | -53.71 | 0.00 | -60.88 |
| Interest Coverage Ratio | -54.10 | 0.00 | -54.10 | 0.00 | 0.00 |
| Debt to Market Cap | 0.15 | 0.00 | 15.49 | 0.00 | 0.00 |
| Interest Debt Per Share | 5.71 | 0.00 | 22.97 | 7.91 | 5.48 |
| Net Debt to EBITDA | 0.79 | 0.38 | 0.79 | 0.38 | 0.30 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.26% | 8.38% | 24.40% | 16.25% |
| EBIT Margin | 0.00% | -725.77% | -2054.19% | -701.11% | -548.80% |
| EBITDA Margin | 0.00% | -680.64% | -2052.88% | -685.54% | -539.35% |
| Operating Profit Margin | 0.00% | -725.77% | -2067.54% | -701.11% | -548.80% |
| Pretax Profit Margin | 0.00% | -725.00% | -2092.41% | -701.02% | -548.70% |
| Net Profit Margin | 0.00% | -725.00% | -2324.08% | -701.02% | -548.70% |
| Continuous Operations Profit Margin | 0.00% | -725.00% | -2092.41% | -701.02% | -548.70% |
| Net Income Per EBT | 111.07% | 100.00% | 111.07% | 100.00% | 100.00% |
| EBT Per EBIT | 101.20% | 99.89% | 101.20% | 99.99% | 99.98% |
| Return on Assets (ROA) | -28.09% | -201.46% | -28.09% | -159.86% | -167.76% |
| Return on Equity (ROE) | -52.85% | -223.08% | -52.85% | -230.28% | -278.13% |
| Return on Capital Employed (ROCE) | -25.51% | -223.31% | -25.51% | -219.52% | -243.91% |
| Return on Invested Capital (ROIC) | -25.51% | -223.31% | -25.51% | -208.79% | -234.67% |
| Return on Tangible Assets | -30.23% | -201.46% | -30.23% | -159.86% | -167.76% |
| Earnings Yield | -21.19% | -0.33% | -2130.62% | -577.52% | -9.59% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 11.30 | 382.00 | 6.76 | 17.20 |
| Payables Turnover | 0.00 | 6.22 | 1.33 | 1.25 | 1.16 |
| Inventory Turnover | 0.00 | 2.44 | 0.00 | 1.18 | 1.79 |
| Fixed Asset Turnover | 0.00 | 6.55 | 0.00 | 2.50 | 3.44 |
| Asset Turnover | 0.00 | 0.28 | 0.01 | 0.23 | 0.31 |
| Working Capital Turnover Ratio | 0.00 | 0.28 | 0.05 | 0.39 | 0.23 |
| Cash Conversion Cycle | 0.00 | 123.30 | -274.36 | 71.66 | -87.73 |
| Days of Sales Outstanding | 0.00 | 32.29 | 0.96 | 54.01 | 21.23 |
| Days of Inventory Outstanding | 0.00 | 149.66 | 0.00 | 310.39 | 204.41 |
| Days of Payables Outstanding | 0.00 | 58.64 | 275.31 | 292.74 | 313.36 |
| Operating Cycle | 0.00 | 181.95 | 0.96 | 364.40 | 225.64 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -6.06 | -0.02 | -24.36 | -182.44 | -92.21 |
| Free Cash Flow Per Share | -6.09 | -0.02 | -26.38 | -184.97 | -92.32 |
| Dividend Paid and CapEx Coverage Ratio | -184.18 | 0.00 | -12.05 | -72.13 | -810.82 |
| Capital Expenditure Coverage Ratio | -184.18 | 0.00 | -12.05 | -72.13 | -810.82 |
| Operating Cash Flow Coverage Ratio | -1.08 | 0.00 | -1.08 | -23.07 | -16.83 |
| Operating Cash Flow to Sales Ratio | 0.00 | -7.34 | -18.32 | -7.24 | -4.85 |
| Free Cash Flow Yield | -16.80% | -0.34% | -1819.11% | -604.49% | -8.49% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.62 | -299.31 | -0.05 | -0.17 | -10.42 |
| Price-to-Sales (P/S) Ratio | 0.00 | 2170.01 | 1.09 | 1.21 | 57.19 |
| Price-to-Book (P/B) Ratio | 2.49 | 667.70 | 0.02 | 0.40 | 28.99 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.95 | -295.65 | -0.05 | -0.17 | -11.78 |
| Price-to-Operating Cash Flow Ratio | -5.98 | -295.65 | -0.06 | -0.17 | -11.80 |
| Price-to-Earnings Growth (PEG) Ratio | 0.08 | 3.37 | 0.00 | -0.00 | 0.18 |
| Enterprise Value Multiple | -4.55 | -318.44 | 0.74 | 0.20 | -10.30 |
| Enterprise Value | 35.70M | 1.69B | -5.77M | -1.60M | 102.24M |
| EV to EBITDA | -4.55 | -318.44 | 0.74 | 0.20 | -10.30 |
| EV to Sales | 0.00 | 2167.45 | -15.12 | -1.36 | 55.56 |
| EV to Free Cash Flow | -5.07 | -295.30 | 0.76 | 0.19 | -11.45 |
| EV to Operating Cash Flow | -5.10 | -295.30 | 0.83 | 0.19 | -11.46 |
| Tangible Book Value Per Share | 12.60 | 0.01 | 50.65 | 76.74 | 37.53 |
| Shareholders’ Equity Per Share | 14.54 | 0.01 | 58.45 | 76.74 | 37.53 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 1.33 | 25.21 | 19.02 |
| Net Income Per Share | -7.68 | -0.02 | -30.89 | -176.72 | -104.37 |
| Tax Burden | 1.11 | 1.00 | 1.11 | 1.00 | 1.00 |
| Interest Burden | 1.02 | 1.00 | 1.02 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 1.68 | 8.20 | 1.41 | 0.94 |
| SG&A to Revenue | 0.00 | 5.58 | 12.48 | 4.04 | 3.19 |
| Stock-Based Compensation to Revenue | 0.00 | 0.29 | 1.48 | 0.23 | 0.22 |
| Income Quality | 0.88 | 1.01 | -1.16 | 1.03 | 0.88 |
Currency in USD
